March 3, 2021
Carolyn Anderson, Simón-Ellebracht Professor in Medicinal Chemistry and professor of radiology at the University of Missouri, is a world-class radiopharmaceutical researcher who has devoted her career to improving diagnostic imaging and treating diseases such as cancer and sickle cell disease.
As part of the NextGen Precision Health initiative, Anderson and her lab will lead the Molecular Imaging and Theranostics Center in developing targeted radiopharmaceutical therapy agents, either alone or in combination with immune-based therapies, to battle melanoma and other types of cancer. The goal is to kill cancer cells with less damage to the body — improving the patient’s quality of life.
NextGen Precision Health
Highlighting the promise of personalized health care and the impact of large-scale interdisciplinary collaboration, the University of Missouri System’s NextGen Precision Health initiative is bringing together innovators from across the system’s four research universities in pursuit of life-changing precision health advancements. It’s a collaborative effort to leverage the strengths of Mizzou and the entire UM System toward a better future for Missouri’s health. An important part of the initiative is the construction of the new NextGen Precision Health building, which will expand collaboration between researchers, clinicians and industry leaders in a state-of-the-art research facility.